The global nebulizers market size reached USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.14% during 2025-2033.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 1.5 Billion |
Market Forecast in 2033
|
USD 2.6 Billion |
Market Growth Rate 2025-2033 | 6.14% |
Nebulizers are devices that are used by patients suffering from respiratory diseases to administer the medication directly into the lungs. Usually made up of a motor, mouthpiece, cup and tubing, these devices turn liquid medicine into a fine mist by using oxygen, compressed air or ultrasonic power for breaking up the liquid drug into aerosols. They are prescribed by doctors to people who are unable to breathe deeply while using an inhaler. Nebulizers are primarily utilized for providing relief from extreme breathing conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc.
Rising prevalence of chronic respiratory diseases is a major factor boosting the growth of the market. Busy schedules, sedentary lifestyles and a lack of physical activities have led to an increase in prevalence of obesity across the globe. This, in confluence with escalating consumption of tobacco and alcohol, is significantly contributing to the increasing occurrence of respiratory disorders, thereby bolstering the sales of nebulizers. Apart from this, rising pollution levels on account of increasing adoption of private vehicles and expansion of industries is another key factor that is contributing to the product’s demand globally. Moreover, the growing geriatric population has led to an increase in the demand for home healthcare devices, which is driving the demand for portable variants. Furthermore, several organizations are taking initiatives to spread awareness about the available treatment options for respiratory diseases. For instance, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) is actively educating the public about the risks posed by COPD and the treatment of the same.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nebulizers market report, along with forecasts at the global and regional level from 2025-2033. Our report has categorized the market based on product type, portability, end-user and application.
Breakup by Product Type:
Breakup by Portability:
Breakup by End-User:
Breakup by Application:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc. and Graham Field (GF) Health Products, Inc.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product Type, Portability, End-User, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Companies Covered | Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc., Graham Field (GF) Health Products, Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global nebulizers market was valued at USD 1.5 Billion in 2024.
We expect the global nebulizers market to exhibit a CAGR of 6.14% during 2025-2033.
The rising prevalence of chronic respiratory diseases, along with the increasing utilization of nebulizers for providing relief from extreme breathing conditions, such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, etc., is primarily driving the global nebulizers market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of nebulizers for providing immediate relief to the critical-ill coronavirus-infection patients, thereby positively influencing the market growth.
Based on the product type, the global nebulizers market has been divided into pneumatic nebulizers, ultrasonic nebulizers, mesh nebulizers, and others. Among these, pneumatic nebulizers currently exhibit a clear dominance in the market.
Based on the portability, the global nebulizers market can be categorized into portable nebulizers and standalone nebulizers. Currently, standalone nebulizers account for the majority of the global market share.
Based on the end-user, the global nebulizers market has been segregated into hospitals and clinics, long term healthcare centers, homecare settings, and outpatient settings. Among these, hospitals and clinics currently hold the largest market share.
Based on the application, the global nebulizers market can be bifurcated into COPD, cystic fibrosis, asthma, and others. Currently, asthma exhibits a clear dominance in the market.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global nebulizers market include Briggs Medical Service Company, Ca-Mi SRL, Besco Medical, Flyp Nebulizers, DeVilbiss Healthcare International, Omron Corporation, Becton, Dickinson and Company, Koninklijke Philips N.V., Feellife Health Inc., Invacare Corporation, Pari Medical Ltd., Philips Respironics, Inc., Agilent Technologies, Inc., Medline Industries, Inc., and Graham Field (GF) Health Products, Inc.